Experimental COVID-19 pill reduces hospitalizations and deaths, Merck says
An experimental COVID-19 pill reduced hospitalizations and deaths by half in people recently infected with the coronavirus, Merck & Co. said, adding that it would soon ask health officials in the U.S. and around the world to authorize its use.
An experimental COVID-19 pill reduced hospitalizations and deaths by half in people recently infected with the coronavirus, Merck & Co. said, adding that it would soon ask health officials in the U.S. and around the world to authorize its use.
We're always looking for ways to make newsletters better for you, and would love your feedback on how Breaking News could be improved. Email your thoughts, suggestions, or complaints to:
No comments:
Post a Comment